INUS
Straddle Chart

Markets / Mutual funds / Sectoral / Thematic

Mutual fundsSIF

Tata India Pharma & Healthcare Fund - Direct Plan - Growth

NAVs of 6 Nov 2026

Tata Mutual Fund · Equity fund · Direct plan · Growth

Sectoral / ThematicDirect · GrowthRisk: Very High
NAV · 5 Nov 2026
₹38.7008 ▲ 0.05%
Tata Mutual Fund
Fund size₹1,534 crJuly - September 2026
1-month range₹35.75 – 38.70
1 year+6.72%rank 68 of 236
Expense ratio1.10%direct plan, a year
5 years+15.49%a year

What the fund does

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

BenchmarkBSE Healthcare TRI
Launched28 Dec 2015
Fund houseTata Mutual Fund
Fund managersRajat Srivastavasince 16 Sept 2024

NAV history

363840 2026-08-112026-08-242026-09-042026-09-182026-10-012026-10-152026-10-29

Returns

1 week
+3.09%avg 4.3%
1 month
+1.87%avg 2.3%
3 months
-3.15%avg -2.0%
6 months
+5.27%avg 2.9%
This year
+9.41%avg 3.9%
1 year
+6.72%avg 4.0% · #68/236
3 years (a year)
+19.65%avg 15.0% · #31/146
5 years (a year)
+15.49%avg 12.8% · #32/106

Bars: this plan; the thin mark is the Sectoral / Thematic average (direct plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+2.9
2025-6.2-9.3+7.9+2.2+0.2+2.4+3.7-1.7-1.3+2.6+0.7-2.1
2026-5.4+5.3-6.3+7.0+4.1+3.7+4.4+0.6-4.4-1.4+2.5

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 31 Oct 2026

Stocks held4041 lines in all
Top 10 stocks50.2%of the fund
Equity99.7%stocks and equity derivatives
Debt & cash0.2%everything else

Where the money is

Equity 99.7%Cash & others 0.2%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
63.7%
Healthcare Services
25.5%
Fertilizers & Agrochemicals
4.2%
Chemicals & Petrochemicals
3.5%
Personal Products
1.3%
Food Products
1.1%
Healthcare Equipment & Supplies
0.5%

Changes since 30 Sept 2026

Share of fund31 Oct 202630 Sept 2026Change
Stocks held99.7%99.7%+0.02
Cash & others0.2%0.2%0.00
Top 10 stocks50.2%50.5%-0.38
Number of stocks4042-2
New stocks 1
  • NESTLE INDIA LTD1.09%
Stocks sold off 3
  • FORTIS HEALTHCARE LTDwas 1.95%
  • MANKIND PHARMA LTDwas 0.77%
  • JUBILANT PHARMOVA LTDwas 0.00%
Bought more 15
  • BIOCON LTD+1.54
  • SANOFI CONSUMER HEALTHCARE INDIA LTD+1.42
  • NATCO PHARMA LTD+1.35
  • TORRENT PHARMACEUTICALS LTD+0.97
  • NAVIN FLUORINE INTERNATIONAL LTD+0.97
  • ASTER DM QUALITY CARE LTD+0.66
  • DR. AGARWALS HEALTH CARE LTD+0.63
  • SAI LIFE SCIENCES LTD+0.62
  • MAX HEALTHCARE INSTITUTE LTD+0.57
  • DR REDDYS LABORATORIES LTD+0.49
  • FDC LTD+0.45
  • ACUTAAS CHEMICALS LTD+0.45
  • ANTHEM BIOSCIENCES LTD+0.42
  • PROCTER & GAMBLE HEALTH LTD+0.40
  • SYNGENE INTERNATIONAL LTD+0.32
Cut back 12
  • PI INDUSTRIES LTD-2.13
  • DR. LAL PATH LABS LTD-1.73
  • CIPLA LTD-1.14
  • ALKEM LABORATORIES LTD-0.96
  • IPCA LABORATORIES LTD-0.91
  • HEALTHCARE GLOBAL ENTERPRISES LTD-0.67
  • SYMBIOTEC PHARMALAB LTD-0.39
  • SUMITOMO CHEMICAL INDIA LTD-0.37
  • ABBOTT INDIA LTD-0.28
  • RAINBOW CHILDRENS MEDICARE LTD-0.28
  • BAYER CROPSCIENCE LTD-0.28
  • DIVI LABORATORIES LTD-0.27

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 40

HoldingSector / type% of fund
SUN PHARMACEUTICAL INDUSTRIES LTD
INE044A01036		Pharmaceuticals & Biotechnology7.89%
ABBOTT INDIA LTD
INE358A01014		Pharmaceuticals & Biotechnology5.66%
DIVI LABORATORIES LTD
INE361B01024		Pharmaceuticals & Biotechnology5.41%
HEALTHCARE GLOBAL ENTERPRISES LTD
INE075I01017		Healthcare Services5.25%
DR REDDYS LABORATORIES LTD
INE089A01031		Pharmaceuticals & Biotechnology5.14%
TORRENT PHARMACEUTICALS LTD
INE685A01028		Pharmaceuticals & Biotechnology4.73%
APOLLO HOSPITALS ENTERPRISE LTD
INE437A01024		Healthcare Services4.55%
MAX HEALTHCARE INSTITUTE LTD
INE027H01010		Healthcare Services4.28%
RAINBOW CHILDRENS MEDICARE LTD
INE961O01016		Healthcare Services4.02%
SAI LIFE SCIENCES LTD
INE570L01029		Pharmaceuticals & Biotechnology3.22%
SYNGENE INTERNATIONAL LTD
INE398R01022		Healthcare Services3.17%
PROCTER & GAMBLE HEALTH LTD
INE199A01012		Pharmaceuticals & Biotechnology3.15%
LUPIN LTD
INE326A01037		Pharmaceuticals & Biotechnology3.13%
CIPLA LTD
INE059A01026		Pharmaceuticals & Biotechnology3.08%
ANTHEM BIOSCIENCES LTD
INE0CZ201020		Pharmaceuticals & Biotechnology2.99%
NATCO PHARMA LTD
INE987B01026		Pharmaceuticals & Biotechnology2.86%
FDC LTD
INE258B01022		Pharmaceuticals & Biotechnology2.69%
BAYER CROPSCIENCE LTD
INE462A01022		Fertilizers & Agrochemicals2.68%
PFIZER LTD
INE182A01018		Pharmaceuticals & Biotechnology2.40%
ACUTAAS CHEMICALS LTD
INE00FF01025		Pharmaceuticals & Biotechnology2.40%
ASTER DM QUALITY CARE LTD
INE914M01019		Healthcare Services2.33%
BIOCON LTD
INE376G01013		Pharmaceuticals & Biotechnology2.23%
NAVIN FLUORINE INTERNATIONAL LTD
INE048G01026		Chemicals & Petrochemicals2.15%
SANOFI CONSUMER HEALTHCARE INDIA LTD
INE0UOS01011		Pharmaceuticals & Biotechnology1.99%
AJANTA PHARMA LTD
INE031B01049		Pharmaceuticals & Biotechnology1.59%
ALKEM LABORATORIES LTD
INE540L01014		Pharmaceuticals & Biotechnology1.40%
DR. AGARWALS HEALTH CARE LTD
INE943P01029		Healthcare Services1.31%
GILLETTE INDIA LTD
INE322A01010		Personal Products1.25%
NESTLE INDIA LTD
INE239A01024		Food Products1.09%
SUMITOMO CHEMICAL INDIA LTD
INE258G01013		Fertilizers & Agrochemicals1.01%
PRASOL CHEMICALS LTD
INE455U01024		Chemicals & Petrochemicals0.85%
GLAXOSMITHKLINE PHARMACEUTICALS LTD
INE159A01016		Pharmaceuticals & Biotechnology0.69%
ZIM LABORATORIES LTD
INE518E01015		Pharmaceuticals & Biotechnology0.57%
MANIPAL HEALTH ENTERPRISES LTD
INE459N01021		Healthcare Services0.57%
MOLBIO DIAGNOSTICS LTD
INE869T01028		Healthcare Equipment & Supplies0.53%
GUJARAT FLUOROCHEMICALS LTD
INE09N301011		Chemicals & Petrochemicals0.51%
SYMBIOTEC PHARMALAB LTD
INE899I01028		Pharmaceuticals & Biotechnology0.48%
PI INDUSTRIES LTD
INE603J01030		Fertilizers & Agrochemicals0.46%
DR. LAL PATH LABS LTD
INE600L01024		Healthcare Services0.03%
IPCA LABORATORIES LTD
INE571A01038		Pharmaceuticals & Biotechnology0.00%

Debt, money market and cash 1

HoldingSector / type% of fund
I) REPO–0.19%

From the fund house's monthly portfolio (tatamutualfund.com), as on 31 Oct 2026. Percentages are of the fund's net assets. Published about ten days after each month ends.

Risk

Volatility12.0%yearly, from daily NAVs
Worst fall-18.19%29 Jul 2016 → 31 Aug 2017
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 31 May 2016).

Fund details

Fund size (average AUM, July - September 2026)₹1,534 cr across all plans · this plan ₹517 cr
Fund houseTata Mutual Fund
CategoryEquity · Sectoral / Thematic
PlanDirect
OptionGrowth
Expense ratio (TER)Direct 1.10% · Regular 2.41% (5 Nov 2026)
Exit load0.25% of NAV if redeemed /switched out before 30 days from the date of allotment.
Minimum investment₹5,000 · additional ₹1,000
Scheme code (AMFI)135810
ISININF277K019A3
NAV date5 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Other plans of this fund

PlanNAV1 year
Direct · IDCW₹37.4422+3.25%
Direct · IDCW₹37.4422+3.25%
Regular · Growth₹32.6613+5.22%
Regular · IDCW₹31.4120+1.19%
Regular · IDCW₹31.4120+1.19%

Top Sectoral / Thematic funds (direct plans)

Fund1 year3 years (a year)
Nippon India Taiwan Equity Fund+49.17%+45.49%
HDFC Defence Fund+18.82%+35.64%
HDFC Pharma and Healthcare Fund+26.22%+31.34%
SBI HEALTHCARE OPPORTUNITIES FUND+20.99%+25.54%
HDFC Transportation and Logistics Fund+9.04%+25.47%
Mirae Asset Healthcare Fund+22.03%+24.65%
UTI - Healthcare Fund+17.27%+24.46%
ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND+10.66%+22.89%
Tata India Pharma & Healthcare Fund+6.72%+19.65%

All Sectoral / Thematic funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of Tata India Pharma & Healthcare Fund - Direct Plan - Growth today?

₹38.7008 as of 5 Nov 2026, from AMFI's official NAV data.

What are the returns of Tata India Pharma & Healthcare Fund - Direct Plan - Growth?

1 year: 6.72%, 3 years: 19.65% a year, 5 years: 15.49% a year

How does Tata India Pharma & Healthcare Fund rank in its category?

68 of 236 Sectoral / Thematic funds (direct plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.